DPP-4 inhibitors
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Formidling
Standard
DPP-4 inhibitors. / Deacon, Carolyn F.
Handbook of incretin therapies in type 2 diabetes. red. / S Gough. Switzerland : Springer, 2016. s. 45-60.Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Formidling
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - DPP-4 inhibitors
AU - Deacon, Carolyn F.
PY - 2016
Y1 - 2016
N2 - Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
AB - Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
U2 - 10.1007/978-3-319-08982-9_4
DO - 10.1007/978-3-319-08982-9_4
M3 - Book chapter
SN - 978-3-319-08981-2
SP - 45
EP - 60
BT - Handbook of incretin therapies in type 2 diabetes
A2 - Gough, S
PB - Springer
CY - Switzerland
ER -
ID: 162893662